Piedmont Investment Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-18,462
| Closed | -$613K | – | 1140 |
|
|
2019
Q1 | $613K | Buy |
18,462
+654
| +4% | +$21.7K | 0.02% | 445 |
|
|
2018
Q4 | $518K | Buy |
17,808
+1,368
| +8% | +$39.8K | 0.02% | 451 |
|
|
2018
Q3 | $756K | Sell |
16,440
-53,739
| -77% | -$2.47M | 0.03% | 372 |
|
|
2018
Q2 | $2.62M | Buy |
70,179
+1,285
| +2% | +$48K | 0.13% | 169 |
|
|
2018
Q1 | $2.04M | Buy |
68,894
+658
| +1% | +$19.4K | 0.05% | 258 |
|
|
2017
Q4 | $2.34M | Sell |
68,236
-676
| -1% | -$23.2K | 0.05% | 241 |
|
|
2017
Q3 | $2.49M | Sell |
68,912
-61,113
| -47% | -$2.21M | 0.05% | 232 |
|
|
2017
Q2 | $3.36M | Buy |
130,025
+45,512
| +54% | +$1.18M | 0.07% | 222 |
|
|
2017
Q1 | $1.62M | Buy |
84,513
+48,036
| +132% | +$922K | 0.03% | 261 |
|
|
2016
Q4 | $608K | Buy |
36,477
+23,139
| +173% | +$386K | 0.01% | 296 |
|
|
2016
Q3 | $274K | Buy |
13,338
+13,310
| +47,536% | +$274K | 0.01% | 359 |
|
|
2016
Q2 | $856 | Hold |
28
| – | – | ﹤0.01% | 381 |
|
|
2016
Q1 | $1.05K | Hold |
28
| – | – | ﹤0.01% | 369 |
|
|
2015
Q4 | $1.21K | Hold |
28
| – | – | ﹤0.01% | 377 |
|
|
2015
Q3 | $1.05K | Hold |
28
| – | – | ﹤0.01% | 385 |
|
|
2015
Q2 | $951 | Hold |
28
| – | – | ﹤0.01% | 395 |
|
|
2015
Q1 | $991 | Hold |
28
| – | – | ﹤0.01% | 306 |
|
|
2014
Q4 | $953 | Sell |
28
-22
| -44% | -$749 | ﹤0.01% | 309 |
|
|
2014
Q3 | $1.93K | Buy |
50
+3
| +6% | +$116 | ﹤0.01% | 249 |
|
|
2014
Q2 | $1.83K | Hold |
47
| – | – | ﹤0.01% | 292 |
|
|
2014
Q1 | $1.61K | Sell |
47
-66
| -58% | -$2.26K | ﹤0.01% | 303 |
|
|
2013
Q4 | $2.37K | Buy |
113
+99
| +707% | +$2.08K | ﹤0.01% | 274 |
|
|
2013
Q3 | $329 | Buy |
+14
| New | +$329 | ﹤0.01% | 304 |
|